首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Preparation of new polycyclic compounds derived from benzofurans and furochromones. An approach to novel 1,2,3-thia-, and selena-diazolofurochromones of anticipated antitumor activities.
【24h】

Preparation of new polycyclic compounds derived from benzofurans and furochromones. An approach to novel 1,2,3-thia-, and selena-diazolofurochromones of anticipated antitumor activities.

机译:制备衍生自苯并呋喃和呋喃色酮的新型多环化合物。一种预期的抗肿瘤活性的新型1,2,3-硫杂-和硒二氮杂呋喃色酮的方法。

获取原文
获取原文并翻译 | 示例
           

摘要

Base catalyzed condensation of enaminoketones (3a,b) with malononitrile yields the respective 7-imino-5[2(substituted)prop-1-enyl]furochromene-6-carbonitriles (4a-d) according to the nature of base used. Compounds (3a, b) condense also with indan-1,3-diketone (5) to give alpha, beta-unsaturated carbonyl compounds (6a) and (6b), respectively. Pyrrolidine-catalyzed condensation of visnaginone (2a) and khellinone (2b) with active methylenes yields the corresponding 1-[7,7-(substituted) furobenzodihydropyrone derivatives (7a-e) which condense with semicarbazide to give the respective semicarbazones (8a-e). Compounds (8b,e) react with thionyl chloride to give the respective 1,2,3-thiadiazoles (9a,b) meanwhile compounds (8a-e) react also with selenium dioxide to give 1,2,3-selenadiazoles (9c-g), respectively. Chalcones (11a,b) were obtained upon condensing (2a,b) with ferrocene-2-carboxaldehyde (10). Compatible elementary and spectroscopic measurements were in good accord with the structures postulated for the new compounds. The antitumor activities of certain selected new compounds were screened, in vitro, against a panel of four (breast: MCF-7, cervix: HELA, colon: HCT116 and liver: HEPG2) human solid tumor cell lines and the structure activity relationship (SAR) was discussed.
机译:根据所用碱的性质,碱催化的氨基酮(3a,b)与丙二腈的缩合反应产生相应的7-亚氨基-5 [2(取代的)丙-1-烯基]呋喃二烯-6-腈(4a-d)。化合物(3a,b)也与茚满-1,3-二酮(5)缩合,分别得到α,β-不饱和羰基化合物(6a)和(6b)。吡喃烷酮催化的visnaginone(2a)和khellinone(2b)与活性亚甲基的缩合反应会生成相应的1- [7,7-(取代)呋喃苯并二氢吡喃酮衍生物(7a-e),将其与缩氨基脲缩合得到相应的半脲基(8a-e) )。化合物(8b,e)与亚硫酰氯反应生成相应的1,2,3-噻二唑(9a,b),同时化合物(8a-e)也与二氧化硒反应生成1,2,3-硒代二唑(9c- g)。通过将二茂铁-2-甲醛(10)缩合(2a,b),得到查耳酮(11a,b)。兼容的元素和光谱测量结果与新化合物的结构十分吻合。体外筛选了某些选定的新化合物对一组四个(乳腺:MCF-7,子宫颈:HELA,结肠:HCT116和肝脏:HEPG2)人实体肿瘤细胞系的抗肿瘤活性及其结构活性关系(SAR) )进行了讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号